High CD163 expression has been associated with poor prognosis in classical Hodgkin’s Lymphoma, since its expression was analogous to vascular endothelial growth factor (VEGF) expression and tumor microvascular density, while high CD163 expression was associated with decreased event-free survival and overall survival of Hodgkin’s Lymphoma patients [69]. This evidence concerns the gene CD163 and neoplasm.